A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment

This study evaluated the efficacy of brief cognitive behavioral therapy (BCBT) for regular methamphetamine use among methadone-maintained women. A randomized controlled trial was conducted in four methadone treatment services. Eligible women were assigned to receive either BCBT or drug education. Fi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychoactive drugs 2019-05, Vol.51 (3), p.280-289
Main Authors: Alammehrjerdi, Zahra, Briggs, Nancy E., Biglarian, Akbar, Mokri, Azarakhsh, Dolan, Kate
Format: Article
Language:English
Subjects:
Amphetamine-Related Disorders - rehabilitation
Behavior modification
Brief cognitive behavioral therapy
Clinical trials
Cognitive behavioral therapy
Cognitive Behavioral Therapy - methods
Cognitive therapy
Female
Follow-Up Studies
Humans
Methadone
Methadone - administration & dosage
Methamphetamine
Methamphetamine - administration & dosage
Opiate Substitution Treatment
treatment
Treatment Outcome
Well being
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study evaluated the efficacy of brief cognitive behavioral therapy (BCBT) for regular methamphetamine use among methadone-maintained women. A randomized controlled trial was conducted in four methadone treatment services. Eligible women were assigned to receive either BCBT or drug education. Five questionnaires were used to assess the research hypotheses at weeks 0, 4, and 12. Urinalysis was used to verify self-reported methamphetamine use at week 0. Urinalyses were used for those participants who reported abstinence from methamphetamine at weeks 4 and 12. Overall, 120 women were enrolled. Sixteen participants were lost to follow-up. Compared with the control group, the treatment group showed significant reductions in frequency of methamphetamine use (p
ISSN:0279-1072
2159-9777
DOI:10.1080/02791072.2019.1578445